Please read and agree to the terms and conditions of this site.
@xconomy.com 3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com 3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com 4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@sallyeaves 4 years ago
New Dawn in #personalised #healthcare Powered by #AI Early #research again demonstrates capacity to target treatment based on #MachineLearning - here related to #lungcancer & #Immunotherapy data @WHO @DomCushnan http://bit.ly/PreciseAI #Health #Medicines #ArtificialIntelligence https://t.co/bv3UJDoN9n
@medical_view 4 years ago
Scientists from @IRBBarcelona, @CRGenomica & @Radboud_Uni have developed an #machinelearning algorithm that can predict which cancer patients are more likely to benefit from #immunotherapy. @FranSupek @BenLehner #AIinHealth https://medicalview.org/ai-system-predicts-which-cancer-patients-benefit-from-immunotherapy/ https://t.co/6p7By58mo4
@xconomy.com 4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com 4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com 4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com 4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com 4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com 4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com 4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com 5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com 5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com 5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com 5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@Primary_Immune 6 years ago
Personas Behind One of 2017's Biggest Medical Breakthroughs http://scopeblog.stanford.edu/2017/12/13/a-very-hopeful-job-saving-the-sickest-kids-with-a-new-leukemia-therapy/ #ITRTG #OpenScience #genomics #leukemia #ChildhoodCancer #RareDisease #OpenScience #BigData #biotech #immunotherapy #science #technology https://t.co/zzUP1ZFSoG